These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1458572)

  • 1. Apolipoprotein B quantified by particle-concentration fluorescence immunoassay.
    Hallaway BJ; Rastogi A; Kottke BA
    Clin Chem; 1992 Dec; 38(12):2387-91. PubMed ID: 1458572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
    Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
    Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of a particular epitope on plasma apolipoprotein B of patients with coronary artery disease.
    Jeng JR; Shieh SM; Chiu HC
    Biochim Biophys Acta; 1993 Jun; 1181(3):287-94. PubMed ID: 7686401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoenzymatic procedure for human apo B-containing particles quantification using monoclonal antibodies.
    Bustos P; Calvo C; Ulloa N; Quiroga A; Sepulveda J
    Hybridoma; 1998 Aug; 17(4):395-401. PubMed ID: 9790075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay.
    Taddei-Peters WC; Butman BT; Jones GR; Venetta TM; Macomber PF; Ransom JH
    Clin Chem; 1993 Jul; 39(7):1382-9. PubMed ID: 7687203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein heterogeneity and its effect on apolipoprotein assays.
    Fruchart JC
    Scand J Clin Lab Invest Suppl; 1990; 198():51-7. PubMed ID: 2111936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B.
    Menys VC; Liu Y; Mackness MI; Caslake MJ; Kwok S; Durrington PN
    Clin Chim Acta; 2003 Aug; 334(1-2):95-106. PubMed ID: 12867279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of lipoprotein particles containing both apolipoprotein AIV and apolipoprotein B in human plasma by a noncompetitive ELISA.
    Ferrer F; Bigot-Corbel E; N'Guyen P; Krempf M; Bard JM
    Clin Chem; 2002 Jun; 48(6 Pt 1):884-90. PubMed ID: 12029004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
    Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
    Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies.
    Bojanovski M; Gregg RE; Wilson DM; Brewer HB
    Clin Chim Acta; 1987 Dec; 170(2-3):271-80. PubMed ID: 3436061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity.
    Jolley ME; Wang CH; Ekenberg SJ; Zuelke MS; Kelso DM
    J Immunol Methods; 1984 Feb; 67(1):21-35. PubMed ID: 6366066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation-enhanced lanthanide fluorescence immunoassay of lipoprotein(a) in serum.
    Jürgens G; Hermann A; Aktuna D; Petek W
    Clin Chem; 1992 Jun; 38(6):853-9. PubMed ID: 1534526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP).
    Koren E; Armstrong VW; Mueller G; Wilson PR; Schuff-Werner P; Thiery J; Eisenhauer T; Alaupovic P; Seidel D
    Atherosclerosis; 1992 Aug; 95(2-3):157-70. PubMed ID: 1418090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
    Meyer E; Westerveld HT; de Ruyter-Meijstek FC; van Greevenbroek MM; Rienks R; van Rijn HJ; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Aug; 124(2):221-35. PubMed ID: 8830935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies can precipitate low-density lipoprotein. II. Radioimmunoassays with single and combined monoclonal antibodies for determining apolipoprotein B in serum of patients with coronary artery disease.
    Marcovina S; Kottke BA; Mao SJ
    Clin Chem; 1985 Oct; 31(10):1659-63. PubMed ID: 3930092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A particle concentration fluorescence immunoassay for prostaglandin D synthase in the rat central nervous system.
    Islam F; Urade Y; Watanabe Y; Hayaishi O
    Arch Biochem Biophys; 1990 Mar; 277(2):290-5. PubMed ID: 2106829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
    Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
    Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncompetitive enzyme-linked immunoassay for apolipoprotein B in serum.
    Fievet C; Koffigan M; Ouvry D; Marcovina S; Moschetto Y; Fruchart JC
    Clin Chem; 1984 Jan; 30(1):98-100. PubMed ID: 6360423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.